A small yeast RNA selectively inhibits internal initiation of translation programmed by poliovirus RNA: specific interaction with cellular proteins that bind to the viral 5'-untranslated region by Das, S. et al.
JOURNAL OF VIROLOGY, Nov. 1994, p. 7200-7211
0022-538X/94/$04.00+0
Copyright C 1994, American Society for Microbiology
A Small Yeast RNA Selectively Inhibits Internal Initiation of
Translation Programmed by Poliovirus RNA: Specific
Interaction with Cellular Proteins That Bind to the Viral
5'-Untranslated Region
SAUMITRA DAS, PETER COWARD,t AND ASIM DASGUPTA*
Department of Microbiology and Immunology and Jonsson Comprehensive Cancer Center, UCLA School of Medicine,
University of Califomia-Los Angeles, Los Angeles, Califomia 90024-1747
Received 24 May 1994/Accepted 2 August 1994
We have purified, sequenced, and prepared a synthetic clone of a small (60-nucleotide) RNA molecule from
the yeast Saccharomyces cerevisiae that had previously been isolated on the basis of its ability to selectively block
the translation of poliovirus mRNA. RNA derived from the clone by transcription with T7 RNA polymerase
appears to block translation initiation by internal ribosome entry (cap independent) but does not significantly
affect cap-dependent translation. Deletion analysis of the poliovirus 5'-untranslated region (5'-UTR) has
shown that yeast inhibitor RNA (I-RNA) requires internal ribosome entry site sequences to inhibit the
translation of poliovirus RNA in vitro. Using a bicistronic RNA construct, we show that I-RNA preferentially
inhibits translation by internal ribosome entry. Gel retardation and UV cross-linking studies demonstrate that
I-RNA specifically binds proteins which interact with RNA secondary structures within the poliovirus 5'-UTR
presumably involved in internal initiation. Specifically, purified I-RNA competes with virus RNA structures
within the 5'-UTR which bind a cellular protein with an approximate molecular mass of 52 kDa. Finally, when
transfected into HeLa cells, I-RNA efficiently inhibits the replication of poliovirus RNA presumably by
inhibiting translation of the input virus RNA.
Poliovirus, the prototype member of the Picomaviridae
family, is a single-stranded, plus-sense RNA virus which mul-
tiplies in the cytoplasm of infected cells. The genome RNA is
approximately 7,500 nucleotides long and codes for a 250-kDa
polyprotein (25, 44). The polyprotein is cleaved by three
virus-encoded proteases, resulting in the synthesis of mature
virus structural and nonstructural proteins. The unusually long
5'-untranslated region (5'-UTR) of poliovirus RNA (750
nucleotides) is highly structured (1, 48) and contains six to
eight upstream AUG codons, none of which appear to be used
in translation (36). Translation of the majority of cellular
mRNAs proceeds by the binding of ribosomes to the 5' cap
structure followed by the scanning of mRNA until the appro-
priate AUG is encountered by the ribosome (27). In sharp
contrast, the translation of naturally uncapped poliovirus RNA
has been shown to be mediated by a mechanism involving the
internal entry of ribosomes near the initiator AUG (39).
Recent studies have demonstrated that the internal entry of
ribosomes requires an element located between nucleotides
320 and 631 within the 5'-UTR of poliovirus RNA (39). This
sequence element has been termed the ribosome landing pad
or, more generally, the internal ribosome entry site (IRES).
Although a number of cellular polypeptides have been impli-
cated in IRES-dependent translation, the precise mecha-
nism(s) of internal initiation of translation remains poorly
understood. In addition to poliovirus, many other picornavi-
ruses have been shown to utilize this novel mechanism for the
initiation of translation (3-6, 21, 22, 28, 29). The RNA
genomes of another picornavirus, hepatitis A, and a flavivirus,
hepatitis C, have been shown to utilize internal ribosome entry
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for translation initiation (16, 26). Two cellular mRNAs, which
encode immunoglobulin heavy-chain binding protein (Bip) and
the Antennapedia protein of Drosophila melanogaster, have
also been shown to use internal initiation of translation (30,
34). All picornavirus mRNAs that utilize IRES-dependent
translation contain a polypyrimidine tract located at the 3'
border of the IRES sequences within the 5'-UTR. Recent
evidence suggests that proper spacing between the polypyrimi-
dine tract and the cryptic AUG at nucleotide 586 of the
poliovirus 5'-UTR is important for viral translation (21, 23,
43).
Accurate translation of poliovirus mRNA in rabbit reticulo-
cyte lysate requires HeLa cell proteins, suggesting the involve-
ment of cellular proteins in internal initiation of translation (8,
14). A 50-kDa protein has been shown to interact with the
RNA stem-loop structure located between nucleotides 186 and
221 in poliovirus type 1 RNA (33). The physiological signifi-
cance of this binding is still unclear. Another protein, called
p52, present in abundance in HeLa cells compared with rabbit
reticulocytes has been found to specifically bind to the stem-
loop structure between nucleotides 559 and 624 of type 2
poliovirus (31). The p52 protein appears to be identical to
human La autoantigen (32). This nuclear protein, recognized
by antibodies from patients with the autoimmune disorder
lupus erythematosus, leaches out of the nucleus into the
cytoplasm in poliovirus-infected HeLa cells. Cell extracts im-
munodepleted with La antibodies fail to promote cap-indepen-
dent translation, and the addition of exogenous purified La
protein corrects aberrant translation of poliovirus RNA in
reticulocyte lysate which contains little or no p52 (32). UV
cross-linking studies have demonstrated that another cellular
protein, p57, interacts with the IRES elements of encephalo-
myocarditis virus (EMCV), foot-and-mouth disease virus, rhi-
novirus, poliovirus, and hepatitis A virus (5, 7, 9, 23, 24, 29, 40,
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42). It has recently been demonstrated that p57 binding to the
IRES of EMCV is identical to that of polypyrimidine tract-
binding protein (PTB), which presumably plays a role in
nuclear splicing (20). Anti-PTB antibody inhibits the transla-
tion of EMCV and poliovirus RNAs, and thus PTB may be be
directly involved in IRES-directed translation. In addition, two
other cellular proteins with molecular masses of 38 and 48 kDa
have previously been shown to specifically interact with RNA
structures spanning nucleotides 286 and 456 of poliovirus.
These two proteins are reported to be present in higher
quantities in HeLa cells than in reticulocyte lysate and appear
to be involved specifically in poliovirus translation (15). An-
other 54-kDa protein cross-links to a region between nucleoti-
des 457 and 626 and is required for the translation of all
mRNAs (15). A very recent report suggests a role for a 97-kDa
protein in the IRES-dependent translation of human rhinovi-
rus RNA (5). RNA-protein complex formation has also been
demonstrated with the regions encompassing nucleotides 98 to
182 and 510 to 629 of poliovirus RNA (12). Taken together,
these results suggest that picornavirus translation involves
direct interaction between cellular factors and RNA sequences
and secondary structures that leads to internal initiation.
trans-acting proteins could direct ribosomes to enter the
mRNA or could alter the RNA structure to facilitate ribosome
binding.
In a previous study, we showed that yeast cells are incapable
of translating poliovirus RNA both in vivo and in vitro and that
this is a consequence of the 5'-UTR of virus RNA (10). It was
found that the inhibitory effect was due to a trans-acting factor
present in yeast lysate that can also inhibit the ability of HeLa
cell extracts to translate poliovirus RNA. Initial characteriza-
tion of this inhibitor showed that it binds to DEAE-Sephacel
and elutes at 1 M potassium acetate. Its activity was heat stable
and resistant to proteinase K digestion, phenol extraction, and
DNase digestion. Interestingly, the inhibitor lost its activity
when digested with RNase, suggesting RNA as the nature of
the inhibitor (10).
Here we report the purification and nucleotide sequence of
inhibitor RNA (I-RNA) from the yeast Saccharomyces cerevi-
siae. A synthetic oligonucleotide representing this sequence
has been cloned. In vitro-expressed RNA from this clone
appears to inhibit internal initiation but not cap-dependent
translation. Using poliovirus 5'-UTR deletion mutants, we
localized the sequences necessary for translation inhibition by
this RNA to a fragment containing the IRES elements. UV
cross-linking results demonstrate that the I-RNA derived from
yeast binds to a number of cellular proteins believed to be
involved in the internal initiation of translation. I-RNA com-
petes with the 5'-UTR of poliovirus RNA for p52 protein and
selectively inhibits the translation of virus mRNA without
affecting host cell protein synthesis. The interaction between
I-RNA and the protein factors needed for internal initiation
appears to be due to the secondary structure of I-RNA, which
closely resembles that of fragments of poliovirus 5'-UTR.
Additionally, we report here that when transfected into HeLa
cells, I-RNA efficiently inhibits the replication of poliovirus
RNA presumably by blocking translation of the input virus
RNA.
MATERIALS AND METHODS
Cells and viruses. HeLa cells were grown in spinner culture
in minimal essential medium (GIBCO Laboratories) supple-
mented with 1 g of glucose per liter and 6% newborn calf
serum. HeLa cell monolayers were grown in tissue culture
flasks in minimal essential medium (GIBCO) supplemented
with 5% fetal bovine serum. The Saccharomyces cerevisiae
strain used, ABYSI (a pral prbl prcl cpsl ade), was kindly
provided by D. Meyer (University of California, Los Angeles).
Extract preparation and in vitro translation. HeLa cell
extracts were prepared as previously described (10, 46). In
vitro translation under HeLa cell extract translation conditions
was performed essentially as described elsewhere (46). Two
micrograms of each mRNA was used with 80 ,ug of HeLa cell
extract in a 25-,ul reaction mixture in the presence of 25 ,uCi of
[35S]methionine (800 Ci/mmol; Amersham) and 40 U of
RNasin (Promega).
Purification ofyeast I-RNA. Yeast cell lysates were prepared
as described previously (47) except that they were not treated
with micrococcal nuclease. Lysates were loaded onto a DEAE-
Sephacel (Pharmacia) column at 0.1 M potassium acetate and
step eluted with buffers containing 0.3, 0.6, and 1 M potassium
acetate. Fractions were dialyzed back to 0.1 M salt and assayed
for translation-inhibitory activity. The 1 M fraction which
showed inhibitory activity was subjected to DNase treatment
and then to proteinase K digestion and phenol-chloroform
extraction. RNA from this fraction was then isolated by alcohol
precipitation. Yeast RNAs that copurified with the 1 M
fraction were dephosphorylated and then 5' end labeled by
kinase reaction. Labeled RNA species were separated on a
20% acrylamide-8 M urea sequencing gel. Labeled and cold
RNA bands run in parallel lanes were eluted from the gel as
follows. Individual gel slices were soaked in 500 ,ul of elution
buffer (2 M ammonium acetate and 1% sodium dodecyl sulfate
[SDS]) at 37°C for 4 h. After brief centrifugation at room
temperature, the supernatant was collected, extracted with
phenol-chloroform (1:1), and alcohol precipitated in the pres-
ence of 20 ,ug of glycogen (Boehringer Mannheim Biochemi-
cals). Precipitated RNA pellets were resuspended in nuclease-
free water and tested for the ability to inhibit translation of
P2CAT RNA (10) in a HeLa cell-free translation system.
I-RNA sequencing. Sequencing of yeast I-RNA was per-
formed with an RNA sequencing kit from U.S. Biochemicals
Corporation. End-labeled RNA was mixed with a base-specific
ribonuclease-buffer combination (following the U.S. Biochemi-
cals protocol), incubated at 50°C, and then loaded onto a 20%
acrylamide-8 M urea sequencing gel.
Cloning of I-RNA. On the basis of the RNA sequence, a
60-nucleotide synthetic oligonucleotide was constructed. The
sense- and antisense-strand-specific oligonucleotides were an-
nealed and then cloned into the pGEM 3Z expression vector
(Promega) between the Hindlll and EcoRI sites in the
polylinker region. The recombinant plasmid was named pS-
DIR (see Fig. 1).
In vitro transcription. mRNAs were transcribed in vitro by
using T7 or SP6 promoters from different linear plasmids with
T7 or SP6 RNA polymerases. The clone pSDIR was linearized
with Hindlll restriction enzyme and then transcribed with T7
RNA polymerase to generate I-RNA (sense transcript). Plas-
mids pG3CAT and P2CAT (10) and deletion mutants (see Fig.
2 and reference 37) were linearized with BamHI, and runoff
transcripts were generated with SP6 RNA polymerase. The
plasmid pBIP-LUC construct was a gift from P. Sarnow (30)
and was linearized with HpaI enzyme and transcribed with T7
RNA polymerase. The poliovirus type 2 IRES-containing
bicistronic construct pGEM CAT/p2-5'/Luc was a gift from N.
Sonenberg and was linearized with XhoI before transcription
with T7 RNA polymerase. Poliovirus 5'-UTR and the frag-
ment spanning nucleotides 320 to 461 were subcloned between
the HindIll and EcoRI sites of the pGEM 3Z vector (Pro-
mega). Both plasmids were linearized with Hindlll and tran-
scribed with T7 RNA polymerase.
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Oligonucleotide templates. Oligodeoxyribonucleotide tem-
plates for transcription by T7 RNA polymerase were synthe-
sized on an Applied Biosynthesis DNA synthesizer and then
purified. Equimolar amounts of the 18-mer T7 primer oligo-
nucleotide and template oligonucleotides were mixed in 0.1 M
NaCl and annealed by heating at 100°C for 5 min and then
slowly cooling to room temperature. The stem-loop B (SL-B),
SL-C, and SL-G RNAs were synthesized in vitro following the
method described above.
RNA transfection. Poliovirus RNA (type 1 Mahoney) was
isolated from infected HeLa cells as described elsewhere (11).
Synthetic I-RNA or poliovirus RNA was mixed with carrier
yeast tRNA to yield a total of 20 ,ug of RNA per transfection
reaction. RNA samples were then mixed with 30 ,ug of
Lipofectin (GIBCO-BRL) and 20 U of RNasin (Promega) and
incubated for 30 min at room temperature. Finally, the sam-
ples were mixed with 4 ml of minimal essential medium
(GIBCO) containing 2.5% fetal bovine serum and were added
to petri dishes containing 70 to 80% confluent HeLa mono-
layer cells. Cells were then incubated at 37°C in a CO2
incubator for 24 h.
In vivo labeling and immunoprecipitation. For in vivo
labeling of proteins after transfection, cells were preincubated
in methionine-free medium (GIBCO) for 40 min at 37°C. Then
100 ,uCi of trans-labeled methionine (specific activity, >1,000
Ci/mmol) was added to each plate, and incubation was contin-
ued for another hour. [35S]methionine-labeled HeLa cell ex-
tract was prepared as described previously (45). In vivo-labeled
viral proteins in transfected cells were detected by immuno-
precipitation with poliovirus anti-capsid antibody (purchased
from American Type Culture Collection). Immunoprecipita-
tions were performed overnight at 4°C with 5 RI of anti-capsid
antibody in a 500-,u reaction volume containing lx RIPA
buffer (5 mM Tris [pH 7.9], 150 mM NaCl, 1% Triton X-100,
0.1% SDS, 1% sodium deoxycholate). Immune complexes
were precipitated with protein A-Sepharose (75 RA of a 20%
solution in RIPA buffer plus 0.2% bovine serum albumin) and
then analyzed on an SDS-14% polyacrylamide gel as described
previously (10).
Mobility shift electrophoresis assay. HeLa S10 cytoplasmic
extract was prepared by collecting the supernatant after cen-
trifugation of the HeLa cell translation extract at 10,000 X g
for 30 min at 4°C. Fifty micrograms of S10 extract was
preincubated at 30°C for 10 min with 4 pRg of poly(dI-dC)(Pharmacia) in a 15-pA reaction mixture containing 5 mM
HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic
acid) (pH 7.5), 25 mM KCI, 2 mM MgCl2, 0.1 mM EDTA,
3.8% glycerol, and 2 mM dithiothreitol. For competition
experiments, 25- to 100-fold excesses of unlabeled competitor
RNAs were added to the reaction and incubated for 10 min at
30°C. Finally, 5 to 10 fmol of labeled RNA probe was added to
respective reaction mixtures and incubation was continued for
another 30 min at 30°C. The nonspecific RNA used in compe-
tition assays was the sequence of the polylinker region (EcoRI
to Hindlll) of the pGem 3Z vector (Promega). Three micro-
liters of gel loading dye was added to the reaction mixture to a
final concentration of 10% glycerol and 0.2% each of bromo-
phenol blue and xylene cyanol. RNA-protein complexes were
then analyzed on a 4% polyacrylamide gel (39:1 ratio of
acrylamide:bis) in 0.5>x TBE.
UV-induced cross-linking. Forty to fifty fmol of 32P-labeled
RNA probes (8 x 104cpm) was incubated with 50 to 100 ,ug of
S10 extract of HeLa cells as described above. After the binding
reaction was complete, samples were irradiated with UV light
from a UV lamp (multiband UV, 254/366NM model U GL;
25UVP, Inc.) at a distance of 3 to 4 cm for 10 min. Unbound
RNAs were then digested with a mixture of 20 jig of RNase A
and 10 U of RNase T1 at 37°C for 30 min. Products were then
analyzed on SDS-14% polyacrylamide gels.
Nucleotide sequence accession number. The nucleotide se-
quence for yeast I-RNA has been submitted to the EMBL
database library under accession number X76506.
RESULTS
Purification of yeast I-RNA. The inhibitor from yeast cells
capable of specifically inhibiting IRES-dependent translation
from poliovirus RNA was initially purified by passage through
a DEAE-Sephacel column (10). The inhibitor bound strongly
to the column and was eluted by washing the column with 1 M
potassium acetate. Previous results from our laboratory
showed that the activity of the inhibitor was not sensitive to
proteinase or DNase treatments or to phenol extraction (10).
Thus, further purification of the DEAE-Sephacel-purified
inhibitor involved DNase and proteinase K digestion followed
by phenol-chloroform extraction. Finally, RNA obtained by
alcohol precipitation of the aqueous phase was labeled with
[-y-32P]ATP at the 5' end and RNA bands were resolved by
20% polyacrylamide-8 M urea gel electrophoresis. Each RNA
band was eluted from gel slices and was assayed for its ability
to inhibit IRES-mediated translation from a poliovirus 5'-
UTR-chloramphenicol acetyltransferase (CAT) construct but
not from a CAT construct known to initiate translation in a
cap-dependent manner (38). A single band which migrated as
a 60-nucleotide RNA was associated with inhibitory activity.
This RNA was sequenced with a commercially available se-
quencing kit. Figure 1A shows the sequence of the 60-nucle-
otide RNA. On the basis of the RNA sequence, sense- and
antisense-strand-specific deoxyoligonucleotides were synthe-
sized, annealed, and then cloned into the pGEM 3Z expression
vector between the HindIII and EcoRI sites in the polylinker
region. The recombinant plasmid was named pSDIR (Fig. 1B).
Transcription by T7 RNA polymerase from the linearized
plasmid resulted in the synthesis of I-RNA. When analyzed by
gel electrophoresis, a single RNA band of approximately 71
nucleotides was detected (Fig. 1C). This consisted of the
60-nucleotide yeast I-RNA as well as 10 extra nucleotides with
the EcoRI site from the 5' polylinker region and 1 nucleotide
at the 3' end from the HindlIl site.
To determine whether RNA synthesized from the synthetic
clone was active, its effect on translation from a CAT construct
containing poliovirus 5'-UTR at the 5' end of the CAT gene
(P2CAT) was determined. Both partially purified inhibitor
from yeast and purified inhibitor transcribed from pSDIR
inhibited translation from the P2CAT RNA in vitro in a HeLa
cell extract (Fig. 1D, lanes 4, 5, and 6). However, translation
from CAT RNA (cap-dependent translation) was not signifi-
cantly inhibited by the presence of these inhibitors (Fig. 1D,
lanes 1, 2, and 3). Quantitation of CAT translation by densi-
tometry showed no significant inhibition from the pG3CAT
construct (Fig. 1D, lanes 2 and 3), while P2CAT translation
was inhibited 40 and 60% (lanes 5 and 6), respectively. Thus,
I-RNA synthesized from the synthetic clone was active in
specifically inhibiting poliovirus IRES-dependent translation
as previously found with partially purified inhibitor from yeast
cells (10).
Poliovirus 5'-UTR sequences required for inhibition by
yeast I-RNA. To determine whether specific sequences within
the 5'-UTR of poliovirus RNA are required for yeast I-RNA
to inhibit IRES-dependent translation, a number of deleted
5'-UTR-CAT constructs were obtained from the laboratory of
J. VIROL.
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A
5'ACGGACGCGC GGGUUUCGAA GUAGCAGAAC
AGCGCAGGAA CCCGGGGAAU GGAAGCCCGG
C
CAT RNA + +
P2CAT RNA - -
1 2
3+ + +
3 45 6
_E"_ <CAT
YEAST INHIBITOR RNA - + - + -
SYNTHETIC INHIBITOR RNA - - + - +
FIG. 1. Nucleotide sequence, cloning, expression, and activity of yeast I-RNA. (A) Sequence of the 60-nucleotide purified yeast I-RNA was
determined as described in Materials and Methods. 5' and 3' termini are indicated. (B) Illustration of the pSDIR plasmid expressing I-RNA. The
positions of the HindIII and EcoRI restriction endonuclease sites are shown. T7 and SP6, the locations of the respective promoters; arrows show
the direction of transcription. (C) I-RNA (sense transcript) was transcribed in vitro with T7 RNA polymerase from plasmid pSDIR linearized with
HindIII restriction enzyme. Four micrograms of synthesized RNA was mixed with denaturing gel loading dye (U.S. Biochemicals), heated at 55°C
for 10 min, and then analyzed on a 1.2% agarose gel along with the 1-kb ladder DNA marker (BRL) (lane M) under conditions for the analysis
of DNA samples. The position of the I-RNA band is indicated. (D) In vitro translation of pG3CAT and P2CAT RNA in HeLa cell translation
lysates was performed in the absence (-) or presence (+) of I-RNA. Two micrograms of pG3CAT RNA or P2CAT RNA was added per reaction
containing 80 jig of HeLa cell lysates. Approximately 4 ,ug of partially purified yeast I-RNA or 1 jig of synthetic I-RNA was used in reactions as
indicated. The location of the CAT gene product is shown by an arrowhead.
N. Sonenberg (McGill University). Figure 2D shows the de-
leted 5'-UTR-CAT constructs used for this purpose. The
inhibitor efficiently inhibited translation from the P2CAT
construct but not from the pG3CAT (or pCAT) construct (Fig.
1D). Almost complete inhibition was observed when the
A5'-33/CAT construct was translated in the presence of I-RNA
(data not shown). Deletion of the first 320 nucleotides from the
5' end of the UTR did not have a significant effect on the
B
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I-RNA - + - +
Cap --++
Deletion Mutants-
B
65-632 A3-631
1 2 3 4 5 6 7 8
46
-~~~~~du. soI-
pG3CAT
DP2CAT ;I: I.
A - 3OCATr
A5'-320/'CAT I::'!'!
;5-632,CAT 1N
320
632
A 3'- 63 1/CJ AT 1:2'
A5'-3 20/A3-4 61 /CAT 1:!,!'i,ih2(k
631
320 461
FIG. 2. Requirement of poliovirus 5'-UTR sequence for the inhibition of translation by yeast I-RNA. (A, B, and C) HeLa cell translation
lysates were used to translate the RNAs listed above the lanes in each panel. In vitro translations were performed with approximately 2 ,ug of either
capped or uncapped RNA as indicated for each deletion mutant construct in the absence (-) or presence (+) of 1 ,ug of purified I-RNA. Each
reaction mixture contained 80 ,ug of HeLa cell lysate. The position of the CAT protein is indicated at the far left. Quantitation of band intensity
for the CAT protein showed inhibition of 55 and 30% in lanes 2 and 4 of panel A; 10, 15, 74, and 25% in lanes 2, 4, 6, and 8 of panel B; and 78
and 39% in lanes 2 and 4 of panel C, respectively. These values were obtained by comparison with respective controls (without I-RNA). (D) The
diagram shows the poliovirus 5'-UTR deletion mutant constructs that were used in the previous experiment. Vertically hatched boxes represent
SP6 RNA polymerase promoters, solid black boxes represent sequences from poliovirus 5'-UTR, and diagonally hatched boxes indicate CAT gene
coding sequences. A number beneath a plasmid represents the nucleotide at the edge of the deletion. The effect of I-RNA on the in vitro
translation of pG3CAT and p2CAT constructs has been shown (Fig. 1D). The results with the A5'-33/CAT construct are not shown.
ability of the inhibitor to inhibit translation from the A5'-320/
CAT construct (Fig. 2A, lanes 1 and 2). Significant inhibition
of translation was observed in the presence of the inhibitor
(Fig. 2A, lanes 1 and 2). Some of the inhibition observed could
be reversed when template RNA was capped prior to transla-
tion (Fig. 2A, lanes 3 and 4). A similar result was obtained with
the A3'-631/CAT construct; almost 75% inhibition of transla-
tion from this construct was observed in the presence of the
inhibitor and the addition of capped RNA reversed the
inhibition of translation to only 25% compared with that of the
control (Fig. 2B, lanes 5 to 8). In contrast, translation from the
A5'-632/CAT construct was almost unaffected by the presence
of the inhibitor (Fig. 2B, lanes 1 and 2). Thus, almost the entire
IRES region of virus RNA (nucleotides 320 to 631) was
required for the inhibitor to efficiently inhibit poliovirus IRES-
dependent translation. A very interesting observation was that
translation from the construct A5'-320/A3'-461/CAT, contain-
ing only nucleotides 320 to 461 of the UTR, was significantly
inhibited by I-RNA (Fig. 2C, lanes 1 and 2). This inhibition can
be overcome to a significant extent by capping RNA prior to
translation (Fig. 2C, lanes 3 and 4). The stimulation of
translation by capping deleted RNAs appears to be due to
cap-dependent translation as cap analogs inhibit stimulated
translation (data not shown). Although almost complete inhi-
bition of IRES-dependent translation by the inhibitor required
almost all of the UTR, significant inhibition was observed with
a construct containing only nucleotides 320 to 461 of the virus
UTR. Because capping RNAs prior to translation prevented
C
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FIG. 3. I-RNA forms a gel-retarded complex which is inhibited by
5'-UTR of poliovirus RNA. 32P-labeled I-RNA was incubated with
HeLa S10 extract in the absence (lane 2) or presence of an unlabeled
25- or 50-fold molar excess of I-RNA (lanes 3 and 4, respectively) or
5'-UTR (lanes 5 and 6, respectively) or of a 50-fold molar excess of
nonspecific RNA (lane 7). Protein-RNA complexes were analyzed on
a nondenaturing gel. In lane 1, S10 extract was not added, i.e., free
probe (FP). C, complex C.
the inhibition of translation to a significant extent, cap-depen-
dent translation was probably not affected by the inhibitor, a
result consistent with our previous observations (10).
I-RNA forms a gel-retarded complex that is inhibited by
UTR. Theoretically, I-RNA could inhibit IRES-dependent
translation by two possible mechanisms. It could bind to some
sequences in the UTR as antisense RNA or it could bind
protein factors needed for the internal entry of ribosomes, thus
inhibiting IRES-dependent translation. The possibility that
yeast I-RNA acts by binding protein factors required for
IRES-dependent translation was plausible for the following
reasons. First, purified RNA was not complementary to 5'-
UTR sequences nor did it hybridize with virus 5'-UTR (data
not shown). Secondly, inhibition of the translation of poliovirus
RNA could be overcome by the addition of increasing concen-
trations of HeLa extract but not of poliovirus RNA or 5'-UTR
sequence (10). Therefore, 32P-body-labeled I-RNA probe was
prepared and mixed with HeLa S10 extracts, and the resulting
RNA-protein complexes were analyzed by nondenaturing
polyacrylamide gel electrophoresis. As shown in Fig. 3, lane 2,
a single complex (denoted C) was clearly evident. The addition
of increasing concentrations of unlabeled I-RNA inhibited the
formation of the labeled complex (Fig. 3, lanes 3 and 4). A
similar result was obtained when unlabeled poliovirus 5'-UTR
was used for competition (Fig. 3, lanes 5 and 6). A nonspecific
RNA, however, was not able to compete with labeled I-RNA
(Fig. 3, lane 7). Thus, I-RNA was able to form a gel-retarded
complex with HeLa S10 proteins(s) that can be specifically
competed with by virus 5'-UTR sequences. It should be noted
that a significant amount of complex C remained in the
presence of cold homologous I-RNA competitor (Fig. 3, lanes
3 and 4). This result is consistent with the UV cross-linking
studies discussed below, showing that many of the cross-linked
bands could not be specifically inhibited by cold I-RNA
competitor. The precise reason for this observation is unclear
at present.
I-RNA binds proteins that interact with poliovirus 5'-UTR.
To determine if specific polypeptides that interact with virus
Extr - + + +t +
I RNA - - + -
Extr.
I-RNA
5-UTR - - - + - UTR
1559 6241
Nsp - - + Nsp
_-#+ v+ +
FIG. 4. I-RNA binds proteins that interact with poliovirus 5'-UTR.
UV cross-linking of 32P-labeled I-RNA with HeLa cell proteins was
performed as described in Materials and Methods. (A) The numbers
to the left refer to the approximate molecular masses of the proteins
that interact with I-RNA. For competition studies, 100-fold molar
excess of unlabeled competitor RNA was added to the binding
reaction. The competitor RNAs used were I-RNA (lane 3), 5'-UTR
(lane 4), and nonspecific (Nsp) RNA (lane 5). (B) The numbers to the
left refer to the molecular masses of protein markers (BRL) (lane M).
The numbers to the right correspond to the molecular masses of
proteins which cross-link to the labeled I-RNA probe. A 100-fold
molar excess of each unlabeled competitor RNA, I-RNA (lane 3),
UTR(559-624) RNA (lane 4), and nonspecific (Nsp) RNA (lane 5),
was used in binding reactions. Extr., HeLa extract.
5'-UTR also interact with yeast I-RNA, a series of UV
cross-linking experiments were performed. In these experi-
ments, body-labeled I-RNA was first incubated with HeLa S10
extract and then cross-linked by using UV light. After ribonu-
clease treatment, protein-nucleotide complexes were analyzed
by SDS-polyacrylamide gel electrophoresis. When 32P-labeled
I-RNA was used to cross-link proteins in HeLa extract, a
number of polypeptides with approximate molecular masses of
100, 70, 52, and 37 kDa were detected (Fig. 4A and B, lanes 2).
The addition of unlabeled I-RNA successfully competed with
the 52-kDa band (Fig. 4A, lane 3). It is unclear at present why
significant amounts of the 100-, 70-, and 37-kDa bands remain
in the presence of unlabeled I-RNA (Fig. 4A, lane 3). When
unlabeled poliovirus 5'-UTR was used as a competitor, the
52-kDa band as well as the 100-, 70-, and 37-kDa bands was
completely inhibited (Fig. 4A, lane 4). In contrast, the addition
of unlabeled nonspecific RNA was unable to inhibit any of the
polypeptides cross-linked to I-RNA (Fig. 4A, lane 5). Because
a 52-kDa protein has previously been shown to interact with a
specific region of virus 5'-UTR (nucleotides 559 to 624), we
determined whether an RNA containing this sequence [called
UTR(559-624)] was able to inhibit the 52-kDa band cross-
linked to labeled I-RNA. As shown in Fig. 4B, lane 4,
unlabeled UTR(559-624) completely inhibited the formation
of the I-RNA-52-kDa complex. Unlike 5'-UTR, UTR(559-
624) only inhibited the 52-kDa band (compare lanes 4 in Fig.
4A and B). These results suggest that yeast I-RNA binds a
52-kDa protein similar to that bound by poliovirus 5'-UTR
nucleotides 559 to 624.
Yeast I-RNA competes with SL-G for protein binding.
* -p52
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FIG. 5. Predicted secondary structure of 5'-UTR of poliovirus RNA. This figure illustrates the probable interaction of various structured RNA
domains with cellular proteins. Molecular masses of the cellular proteins with their possible sites of interaction (indicated by nucleotide numbers
within parentheses) are shown. This figure is a modified version of secondary structure predictions by Pilipenko et al. (43), Jackson et al. (21), and
Dildine et al. (13).
Poliovirus 5'-UTR contains a number of thermodynamically
stable stem-loop structures that are believed to play important
roles in virus RNA replication and translation (Fig. 5). Nucle-
otides 186 to 221, which constitute SL-D, have been shown to
bind a 50-kDa protein (p50) (33). SL-G, representing poliovi-
rus 5'-UTR sequences from nucleotides 559 to 624, binds to a
52-kDa protein (p52) which has recently been identified as the
human La protein (32). The results presented immediately
above suggested that I-RNA interacts with p52, which nor-
mally binds to SL-G within the virus 5'-UTR. To confirm that
similar proteins may be interacting with I-RNA and SL-G, the
following competition experiments were performed. 32P-la-
beled 5'-UTR was incubated with HeLa S10 extract either
alone or in the presence of various unlabeled competing RNAs
(e.g., 5'-UTR, SL-G, I-RNA, SL-B, SL-C, and nonspecific
RNA). The resulting complexes were then analyzed by UV
cross-linking studies. RNA sequences representing SL-B and
SL-C were used as negative controls in these experiments as
these sequences are not likely to interact with p52. When
poliovirus 5'-UTR was used as the labeled probe, almost
complete inhibition of the formation of the 52-kDa protein-
nucleotidyl complex was observed with unlabeled UTR, I-
RNA, and SL-G (Fig. 6A, lanes 3 to 6). Unlabeled SL-B, SL-C,
and nonspecific RNA were relatively ineffective in inhibiting
the binding of 5'-UTR and p52 (Fig. 6A, lanes 7 to 9). Only
unlabeled UTR RNA inhibited the formation of all labeled
bands, whereas I-RNA and SL-G specifically inhibited forma-
tion of the p52 band.
When SL-G was used as the labeled probe, a doublet
migrating to 52 and 54 kDa was detected (Fig. 6B, lane 2).
Homologous competition with unlabeled SL-G completely
inhibited the formation of these complexes (Fig. 6B, lane 3).
Almost 80% inhibition of the formation of these UV cross-
linked complexes was observed in the presence of unlabeled
I-RNA (Fig. 6B, lane 4). However, no inhibition was observed
when nonspecific, SL-B, or SL-C RNA was used as a compet-
itor (Fig. 6B, lanes 5 to 7). Taken together, these results
suggest that similar proteins having approximate molecular
masses of 52 kDa interact with I-RNA and SL-G.
The results presented above suggested that the inhibition of
poliovirus IRES-dependent translation by I-RNA may be
mediated at least in part by its interaction with the 52-kDa
protein. To investigate how I-RNA inhibits translation from
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FIG. 6. Competition UV cross-linking studies with 32P-labeled
5'-UTR (A) and UTR(559-624) (B) probes. (A) UV cross-linking
experiments were performed in the absence (lane 3) or presence of
unlabeled 5'-UTR (lane 4), SL-G [UTR(559-624)] (lane 5), I-RNA
(lane 6), SL-B [UTR(51-78)] (lane 7), SL-C [UTR(124-162)] (lane 8),
and nonspecific RNA (lane 9). Lane 2 contained the probe but no S10
extract. Lane 1 shows the migration of marker proteins. (B) UV
cross-linking was performed in the absence (lane 2) or presence of
unlabeled SL-G (lane 3), I-RNA (lane 4), SL-B (lane 5), SL-C (lane 6),
and nonspecific RNA (lane 7). Lane 1 contained the probe but no S10
extract.
YEAST I-RNA AND INTERNAL INITIATION OF TRANSLATION 7207
A B
PROBE: I-RNA 5'UTR UTR(320 -461)
1 2 3 4 5 6 7 8 9 10
I ',*'*
I-RNA UTR(320-461)
1 2 3 4 5 6
-4
-4
FIG. 7. Competition UV cross-linking studies with 32P-labeled UTR(320-461) probe. (A) 32P-labeled UTR(320-461) probe was incubated with
HeLa extracts in the absence (lane 6) or presence of unlabeled 5'-UTR (lane 7), SL-G (lane 8), I-RNA (lane 9), and nonspecific RNA (lane 10).
Lane 5 contained the 32P-labeled UTR(320-461) probe but no S10 extract. 32P-labeled I-RNA probe was incubated with (lane 2) or without (lane
1) HeLa S10 extract. 32P-labeled 5'-UTR probe was incubated with (lane 4) or without (lane 3) HeLa S10 extract. (B) 32P-labeled I-RNA (lanes
1 and 2) or UTR(320-461) (lanes 3 to 6) was used for UV cross-linking experiments. Lanes: 1, no extract; 2, HeLa S10 extract; 3, no extract; 4,
S10 extract; 5 and 6, same as lane 4 except that unlabeled SL-G RNA or unlabeled nonspecific RNA was used as the competitor, respectively.
Arrowheads indicate the positions of p54 and p52.
the A5'-320/A3'-461/CAT construct (Fig. 2), which does not
contain the p52-binding site, an RNA representing poliovirus
sequence nucleotides 320 to 461 was used as the probe in UV
cross-linking experiments. As shown in Fig. 7A, lane 6, incu-
bation of the labeled probe with HeLa S10 extract resulted in
the formation of a number of protein-nucleotidyl complexes.
Among these bands was a doublet with approximate molecular
masses of 54 and 52 kDa (indicated in the figure by arrow-
heads). The lower band of the doublet comigrated with
protein-nucleotidyl complexes formed with labeled IRNA (Fig.
7A, lane 2) and 5'-UTR (lane 4). To further determine the
nature of the lower band of this doublet, competition experi-
ments were performed with unlabeled UTR, I-RNA, and SL-G
(the p52-binding site). The addition of unlabeled UTR inhib-
ited the formation of many of the bands except the uppermost
and lowermost bands (Fig. 7A, lane 7). In contrast, when
unlabeled SL-G (the p52-binding site) was used as the com-
petitor, only the formation of the lower band of the doublet
was inhibited (Fig. 7A, lane 8). A similar result was obtained
when unlabled I-RNA was used as the competitor (Fig. 7A,
lane 9). However, the addition of unlabeled, nonspecific RNA
did not result in the disappearance of any complex (Fig. 7A,
lane 10). Homologous competition with unlabeled UTR(320-
461) produced results similar to those with the whole UTR
(Fig. 7A, lane 7, and data not shown). Because the protein-
nucleotidyl complexes (54 and 52 kDa) in the doublet were
poorly resolved in Fig. 7A, a similar experiment in which the
bands were better resolved by running the gel for a longer time
was performed (Fig. 7B). Some of the protein-nucleotidyl
complexes in Fig. 7B were not present in high quantities in this
experiment because a lower concentration of S10 was used
here than was used in Fig. 7A. Additionally, the specific activity
of the labeled probe in this experiment was much lower than
that used in the previous experiment. These results suggest
that a polypeptide that interacts with SL-G is also capable of
interacting with nucleotides 320 to 461. Additionally, I-RNA is
able to compete with UTR(320-461) for binding to this pro-
tein.
Yeast I-RNA inhibits IRES-mediated translation in vitro.
We previously showed that partially purified yeast I-RNA
specifically inhibited the translation of monocistronic RNAs
containing poliovirus 5'-UTR. However, cap-dependent trans-
lation of either CAT RNA or yeast mRNA was not affected by
this inhibitor (10). To examine if this cloned and purified RNA
preferentially inhibits internal initiation of translation, its
effect on translation from a bicistronic messenger was deter-
mined. For this purpose, a bicistronic construct containing
CAT and luciferase genes flanked by the poliovirus 5'-UTR
was obtained from N. Sonenberg. The initiation of translation
occurring internally from the poliovirus 5'-UTR would result
in the synthesis of luciferase, whereas cap-dependent transla-
tion would normally produce CAT protein. In uninfected
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FIG. 8. I-RNA inhibits internal initiation of translation in vitro.
(A) A bicistronic construct containing the CAT and luciferase (LUC)
genes flanked by type 2 poliovirus 5'-UTR was translated in vitro in
HeLa cell lysates in the absence (lane 1) or presence (lane 2) of 1 ,ug
of I-RNA. Products were analyzed on an SDS-14% polyacrylamide gel.
(B) p2CAT RNA (lanes 1 and 2) and capped pGEMLuc mRNA (lanes
3 and 4) (2 ,ug each) were translated in vitro in HeLa cell lysate in the
absence (lanes 1 and 3) or presence (lanes 2 and 4) of 1 ,ug of I-RNA.
(C) The pBIP-LUC construct containing the 5'-UTR of Bip mRNA
linked to a reporter (LVC) gene was translated in vitro in HeLa cell
lysates in the absence (lane 1) or presence (lane 2) of 1 ,ug of yeast
inhibitor. As a control, the pG3CAT construct was also translated in
the absence (lane 3) or presence (lane 4) of the yeast inhibitor.
Products were analyzed on an SDS-14% polyacrylamide gel. Arrow-
heads indicate the positions of the LUC gene product and the CAT
gene product.
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FIG. 9. I-RNA inhibits the translation of poliovirus RNA in vivo. HeLa monolayer cells were transfected with virus RNA alone, I-RNA alone,
or virus RNA and I-RNA together. After transfection, cells were labeled with [35S]methionine and in vivo-labeled proteins were analyzed on an
SDS-14% polyacrylamide gel either directly (A) or after immunoprecipitation with anti-capsid antibody (B) as described in Materials and Methods.
(A) RNAs added to each transfection reaction are indicated. Transfection reaction mixtures contained 1 or 2 ,ug of poliovirus RNA (PV-RNA)
and 3 ,ug of I-RNA. (B) Immunoprecipitation of the in vivo-labeled proteins from the transfection reactions in lanes 1 to 5 of panel A. The positions
of the poliovirus capsid proteins are indicated on the left. (C) PV-RNA (1.5 ,ug) was transfected either alone or together with I-RNA and/or
antisense I-RNA as indicated (3 ,ug each). The total RNA concentration in each transfection was adjusted to 20 p.g by adding carrier tRNA.
HeLa cell extracts, translation from the capped bicistronic
message produced both CAT and luciferase proteins (Fig. 8A,
lane 1). In the presence of purified yeast inhibitor, significant
inhibition of luciferase synthesis was observed, whereas the
synthesis of CAT was almost completely unaffected. Quantita-
tion of the labeled CAT and luciferase bands showed that
while luciferase synthesis was inhibited by over 70% compared
with the control, no inhibition of CAT synthesis was observed
in the presence of the inhibitor. When bicistronic RNA was
translated in virus-infected cell extract, no CAT synthesis was
detected as cap-dependent translation is inhibited in virus-
infected cells (data not shown). The addition of purified
inhibitor completely inhibited luciferase synthesis in infected
extract (data not shown). These results suggest that yeast
I-RNA preferentially inhibits the internal initiation of transla-
tion programmed by poliovirus 5'-UTR.
Recent results have shown that a few cellular mRNAs can
initiate translation internally (30, 34). The immunoglobulin
heavy-chain Bip protein is among the proteins that can be
synthesized by internal initiation. To determine whether Bip
synthesis can be specifically inhibited by I-RNA, a construct
containing the 5'-UTR of Bip mRNA linked to a reporter gene
(luciferase) was obtained from P. Sarnow (University of Col-
orado). The translation of this mRNA in HeLa extracts
generated the luciferase protein (Fig. 8C, lane 1). The addition
of yeast I-RNA completely inhibited luciferase synthesis from
this RNA construct (Fig. 8C, lane 2). As expected, cap-
dependent translation from a CAT construct was not at all
inhibited under the same conditions (Fig. 8C, lanes 3 and 4). In
fact, CAT translation was significantly stimulated over that of
the control as previously observed (10). These results suggest
that yeast I-RNA is capable of inhibiting internal initiation
from a cellular mRNA.
To examine the possibility that luciferase translation from
the Bip UTR construct was nonspecifically inhibited by I-
RNA, a monocistronic luciferase construct which did not
contain the Bip IRES sequence was obtained. Translation
from this construct is known to occur by a cap-dependent
mechanism. Translation from this RNA was inhibited by only
7% in the presence of the inhibitor compared with the control
(Fig. 8B, lanes 4 and 3, respectively). Under similar conditions,
translation from the poliovirus IRES containing the P2CAT
construct was inhibited by 72% compared with the control
(Fig. 8B, lanes 1 and 2).
Yeast I-RNA inhibits the translation of poliovirus RNA in
vivo. Previous studies from our laboratory (10) and the results
presented here suggested that yeast I-RNA inhibits virus
IRES-dependent translation in vitro. To determine whether
I-RNA inhibits the translation of poliovirus RNA in vivo,
poliovirus RNA was transfected into HeLa cells singly or
together with purified yeast RNA. Proteins were labeled by the
addition of [3 S]methionine, and the synthesis of viral proteins
was monitored by direct analysis of cell extracts (Fig. 9A) or by
immunoprecipitation of viral capsid proteins by anti-capsid
antisera (Fig. 9B). In the absence of added virus RNA and
I-RNA, the synthesis of cellular proteins was evident (Fig. 9A,
lane 1). When virus RNA (1 ,ug) was transfected into cells, the
synthesis of distinct viral proteins was observed (Fig. 9A, lane
2). In addition, the background of host cell proteins diminished
considerably because of the shutoff of host cell protein synthe-
sis by poliovirus (Fig. 9A, lane 2). When I-RNA was cotrans-
fected with virus RNA (1 ,ug) into HeLa cells, no detectable
synthesis of viral proteins was observed and host cell protein
synthesis was restored (Fig. 9A, lane 3). The expression of
I-RNA alone did not interfere with the synthesis of cellular
proteins (Fig. 9A, lane 4). Figure 9A, lane 5, shows that the
carrier tRNA used in transfection experiments had no effect on
cellular protein synthesis. The transfection of cells with an
increased amount of poliovirus RNA (2 ,ug) resulted in the
synthesis of viral proteins and a more pronounced shutoff of
PV-RNA
tRNA
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cellular protein synthesis (Fig. 9A, lane 6). However, in the
presence of I-RNA, viral protein synthesis was inhibited and
host cell protein synthesis was restored (Fig. 9A, lane 7) to the
level seen in the control reaction. The results shown in Fig. 9B
confirm that viral protein synthesis was inhibited in cells
containing I-RNA. The synthesis of viral capsid proteins was
inhibited in cells cotransfected with virus RNA and I-RNA
(Fig. 9B, lane 3). Thus, yeast I-RNA efficiently inhibited
translation from poliovirus RNA in vivo. Although not shown
here, the protection of monolayer cells from the cytolytic
effects of poliovirus infection in the presence of yeast I-RNA
paralleled the restoration of host cell protein synthesis seen in
lanes 3 and 7 of Fig. 9A.
Figure 9C represents an experiment similar that shown in
Fig. 9A except that two important controls are included. First,
the transfection of an unrelated nonspecific RNA similar in
size to I-RNA along with poliovirus RNA did not result in the
inhibition of viral protein synthesis (compare lanes 2 and 5 in
Fig. 9C). Secondly, the translation-inhibitory effect of I-RNA
in cotransfected cells (Fig. 9C, lane 4) was reversed by includ-
ing equimolar amounts of antisense I-RNA during transfection
(lane 3). These experiments suggested that the inhibition of
virus translation in cotransfected cells is mediated by I-RNA. It
should be noted that similar amounts of intracellular poliovirus
RNA were detected in cells transfected with poliovirus RNA
alone and in cells transfected with a mixture of poliovirus RNA
and I-RNA, suggesting that the stability of poliovirus RNA is
not altered significantly in cells containing I-RNA (data not
shown).
DISCUSSION
Poliovirus RNA is poorly translated in the yeast S. cerevisiae
both in vivo and in vitro (10). A previous study from our
laboratory identified an RNase-sensitive activity from yeast
cells which was able to inhibit (in trans) the translation of
poliovirus RNA in HeLa cell extracts. The inhibitor had no
effect on cap-dependent translation of a number of mRNAs.
Because naturally uncapped poliovirus RNA uses a cap-
independent mode of translation which utilizes the internal
entry of ribosomes, it was thought that the yeast inhibitor
specifically inhibited IRES-dependent translation. Here we
report the purification of a small RNA molecule (60 nucleo-
tides) from yeast cells which appears to specifically inhibit
IRES-mediated translation programmed by poliovirus RNA.
This small RNA inhibitor (I-RNA) has been sequenced, and a
synthetic clone has been prepared according to the RNA
sequence. RNA derived from the synthetic clone by transcrip-
tion with T7 RNA polymerase blocks the translation of polio-
virus RNA both in vivo and in vitro. Several lines of evidence
suggest that purified yeast RNA specifically inhibits the inter-
nal initiation of translation mediated by poliovirus IRES. First,
deletion analysis of poliovirus 5'-UTR has shown that I-RNA
requires internal ribosome entry site sequences to efficiently
inhibit the translation of poliovirus 5'-UTR-CAT RNAs (Fig.
2). Secondly, using a bicistronic construct which contains the
poliovirus IRES between two cistrons, we have shown that
translation from the second cistron is specifically inhibited by
I-RNA, whereas translation from the first cistron is not af-
fected at all by the inhibitor (Fig. 8). The translation of
poliovirus RNA in vivo is inhibited when cells are cotrans-
fected with virus RNA and I-RNA (Fig. 9). This inhibition can
be reversed by the inclusion of an equimolar amount of
antisense I-RNA during cotransfection. Additionally, transla-
tion mediated by the 5'-UTR of Bip mRNA, which is known to
initiate translation internally, is also inhibited by I-RNA (Fig.
8). Finally, I-RNA appears to specifically interact with at least
one polypeptide (p52) believed to be involved in the internal
initiation of translation (Fig. 4 and 6).
How I-RNA inhibits the translation of poliovirus mRNA is
not clear at present. Our UV cross-linking studies suggest that
I-RNA interacts with a protein with an apparent molecular
mass of 52 kDa present in HeLa S10 extract. We assume,
although we have not shown, that this protein is similar to the
p52 protein which was originally described as binding to the
poliovirus sequence of nucleotides 559 to 624 (SL-G). The
results presented in Fig. 4 and 6 suggest that this 52-kDa
protein (p52) may also bind to a region of poliovirus UTR(320-
461) in addition to the region spanning nucleotides 559 to 624.
This is similar to what has recently been reported for p57, a
polypeptide which has been identified as PTB. This protein has
been shown to bind to three noncontiguous sites on poliovirus
RNA, nucleotides 7 to 286 (site 1), 443 to 539 (site 2), and 630
to 730 (site 3) (19). p52 binding to multiple regions of
poliovirus RNA may be important for virus RNA translation.
In such a case, it is conceivable that the binding of p52 by
I-RNA may lead to the inhibition of viral protein synthesis.
The binding of p52 to poliovirus RNA sequence 320 to 461
may be important in view of the studies indicating that SL-D
and -G may not be absolutely necessary for virus translation in
vivo (17, 18, 41). It should be noted that cell extracts immu-
nodepleted of p52 fail to promote cap-independent translation
(32). Future studies with purified p52 and anti-p52 antiserum
should enable us to determine if indeed p52 binds to nucleoti-
des 320 to 461 of poliovirus RNA. At present, the possibility
that the 52-kDa polypeptide that interacts with nucleotides 320
to 461 of virus RNA is not related to p52 (i.e., the La
autoantigen) cannot be excluded.
It is clear from deletion analysis that the minimum 5'-UTR
sequence required for the inhibition of translation appears to
be nucleotides 320 to 461 (Fig. 2C). This sequence potentially
forms two stem-loop structures, SL-E and SL-F (Fig. 5).
Dildine and Semler have shown that part of SL-E (nucleotides
260 to 415) is capable of forming RNA-protein complexes with
extracts prepared from many cell types (13). UV cross-linking
studies by Gebhard and Ehrenfeld have shown that two
proteins with apparent molecular masses of 48 and 38 kDa
bind to the region covering SL-E and -F and that these
proteins are believed to be important for virus translation (15).
The relationship between the 52-kDa protein that binds to
nucleotides 320 to 461 (Fig. 7) and the 48-kDa protein seen by
Gebhard and Ehrenfeld remains unclear at present.
Purified yeast I-RNA is able to inhibit virus replication in
cells transfected with poliovirus RNA presumably by inhibiting
virus translation (Fig. 9). First, poliovirus-specific proteins are
not detected in cells cotransfected with poliovirus mRNA and
I-RNA. Secondly, host protein synthesis is restored in cotrans-
fected cells, demonstrating the absence of viral proteins in
these cells. Finally, immunoprecipitation with anti-capsid an-
tibody confirms the absence of viral proteins in cells trans-
fected with I-RNA. In addition, the translation (viral)-inhibi-
tory effect of I-RNA in cotransfected cells can be reversed by
including equimolar amounts of antisense I-RNA during trans-
fection (Fig. 9C). Although we have not determined whether
the synthesis of specific cellular proteins is inhibited in vivo,
gross cellular protein synthesis does not appear to be affected
by the presence of this inhibitor. Why do we see almost
complete restoration of host cell protein synthesis (i.e., the lack
of productive infection) although only 15 to 20% of cells are
transfected with I-RNA? The answer lies in the fact that
liposome-mediated cotransfection results in a high percentage
of transfected cells which carry both virus RNA and I-RNA. In
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other words, there are very few cells that are transfected with
virus RNA alone during cotransfection. This results in almost
total inhibition of viral protein synthesis. In contrast, cells
transfected with virus RNA alone are able to produce progeny
virions which cause spreading infection, eventually resulting in
the lysis of almost all cells. Thus, in the absence of I-RNA, we
see an amplified effect of virus infection.
Since both virus RNA (5'-UTR) and I-RNA bind similar
proteins involved in the internal initiation of translation, is
there any sequence homology between these two RNAs? We
found no significant homology between I-RNA and poliovirus
mRNA. We have searched for sequences similar to the I-RNA
sequence by using FASTA (35) on a Biovax copy of the
Genetics Computer Group-formatted GenBank files for three
databases, namely, virus RNA, structural RNA, and plants,
including yeasts (Sept. 1993 version). Interestingly, 89.5%
homology (with a 19-nucleotide overlap) with a region of the
Japanese encephalitis virus genome was found. Similarly, 70 to
80% homology was observed with different regions of the
genomes of herpes simplex virus, Sindbis virus, Epstein-Barr
virus, dengue virus, and influenza virus. Compared with the
structural RNA database, the most striking homology (79 to
100%, with an 11- to 19-nucleotide overlap) was with 16S
rRNAs from a variety of organisms. I-RNA also has extensive
homology (93.8%, with a 16-nucleotide overlap) with 5S rRNA
of trypanosomes. Comparison with the plant database, which
includes yeasts, showed 93.3% homology (15-nucleotide over-
lap) with the yeast genes of histones H4.1 and H3. The only
mRNA found to have homology with I-RNA was maize
superoxide dismutase 3 isoenzyme (100% homology, with a
13-nucleotide overlap). Considering the shortness of the over-
lapping sequences, the significance of these findings is unclear
at present.
It is worth noting that an antisense RNA with an exact
complementary sequence of I-RNA is as efficient in binding
p52 as the sense I-RNA molecule (data not shown). This
result, taken together with the fact that there is no apparent
sequence homology with poliovirus RNA, suggests that the
secondary structure of I-RNA may play a crucial role in the
inhibition of internal initiation of translation. Indeed, two
computer-predicted secondary structures of I-RNA that are
thermodynamically relatively stable could be generated (data
not shown). These structures partly resemble the p52-binding
site on poliovirus mRNA. Thus, it may be the secondary
structure rather than the primary sequence of I-RNA that is
responsible for its ability to bind p52 or other proteins neces-
sary for the internal initiation of translation.
The normal function of I-RNA in yeast cells remains
unknown at present. Altman et al. previously reported that a
strain of S. cerevisiae can translate (albeit inefficiently) UTR-
CAT gene fusions present as the second gene in bicistronic
RNAs (2). An intriguing possibility is that yeast cells contain
genes which initiate translation internally and that I-RNA can
be used to regulate the expression of these genes posttranscrip-
tionally. So far, two cellular mRNAs, one encoding the immu-
noglobulin heavy-chain Bip protein and the other encoding the
Drosophila Antennapedia protein, have been shown to be
translated by a mechanism involving internal ribosome entry.
We have shown here that purified I-RNA inhibits the in vitro
translation programmed by Bip 5'-UTR (Fig. 8). In studies to
be published elsewhere, we have shown that the inhibitor
specifically inhibits the translation of other picornaviruses,
including rhino-, hepatitis A, and Thieler's murine encephalo-
myelitis viruses. Thus, both a cellular RNA and a number of
picornavirus RNAs known to initiate translation internally are
inhibited by the same inhibitor. Future studies should utilize
yeast I-RNA as a probe to understand in detail the mecha-
nism(s) of the internal initiation of translation in eukaryotes.
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